Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 51. Lim S Y, Miller J L, Henry E, Heltsley R, Woo S, Johnson P N. Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children. Pharmacotherapy. 2021; 41 : 359-369
52. Harkin M, Johnson P N, Neely S, White L, Miller J L. Frequency and Severity of Chlorothiazide-Induced Hyponatremia in the Neonatal Intensive Care Unit. American journal of perinatology. 2021
53. Weller B M, Shaddix B P, Oschman A, Johnson P N, Neely S, Chaaban H, Williams P K, Miller J L. A Pilot Evaluation of the Possible Association of Metronidazole With Neurodevelopmental Outcomes in Premature Neonates. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 455-459
54. Nguyen A L, Johnson P N, Neely S, Hughes K M, Sekar K C, Welliver, Sr R C, Miller J L. Comparison of Amikacin Pharmacokinetics in Neonates With and Without Congenital Heart Disease. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 372-378
55. Salemi L A, Sahlstrom A L, Lim S Y, Johnson P N, Dannaway D, Miller J L. Evaluation of the Use of Caffeine Citrate Maintenance Doses 5 mg/kg/day in Preterm Neonates for Apnea of Prematurity. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 608-614
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 16. OU Health Sciences Center Student Government Association. Robert Magarian Faculty Award. Date: 2017.
17. American Association of Colleges of Pharmacy. Walmart Scholar Mentor (for Trisha Lepa). Date: 2016.
18. Pediatric Pharmacy Advocacy Group. Christensen Young Investigator Award (Served as resident mentor). Date: 2016.
19. Pediatric Pharmacy Advocacy Group. Fellow (FPPAG). Date: 2016.
20. Pediatric Pharmacy Advocacy Group. Scholarship in Teaching Award. Date: 2016.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results